• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: May 20-24


In case you missed it, this week we had news about results from BE HEARD I and BE HEARD II published in The Lancet, AbbVie's Clearly Me Campaign, the role of HIF-1-alpha in inflammation and psoriasis, and more.

Dermtology Times Weekly Roundup Logo | Image credit: Dermatology Times

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

QUIZ: Dermoscopy and Melanoma Detection

Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month.

Pearls From the Diversity in Dermatology Conference

Discover pearls on caring for patients with STDs, using dermatopathology in SOC, managing inflammatory skin conditions in women, and ensuring patients are able to access care needed.

Reviewing the Skin Cancer Pipeline: A Look at the Last 10 Years

In recognition of Skin Cancer Awareness Month, Dermatology Times is reviewing research and strides in skin cancer treatment over the last decade.

New Infinity Dermatology and Well Revolution Partnership Expands Dermatology Access in New York

Care Messenger helps to expand care delivery and respond to growing patient needs without placing additional strain on clinicians.

Journal Digest: May 20

This week’s collection of the latest dermatologic studies includes case reports of onychocytic matricoma, congenital triangular alopecia treated with 5% topical minoxidil, systemic therapy usage in vulvar lichen sclerosus and vulvovaginal lichen planus, and dose escalation of interleukin inhibitors in Japanese patients with psoriasis.

RECAP Measurement Validated for Atopic Dermatitis

Results of a recent study show RECAP's impact on adult Asian patients with AD.

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 3

A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.

Your Home Is Your Castle: How to Protect It and Its Equity From Potential Lawsuits

Some states offer great homestead protection, but most provide an inadequate shield. Learn how to protect your greatest assets.

Review Examines Local Procedures Treating Axillary Hyperhidrosis and Osmidrosis

A large amount of studies included in the review centered around the use of botulinum toxin in these indications.

Ayesha Patrick: Advocacy, Representation, and Hope Via AbbVie's Clearly Me Campaign

Ayesha Patrick: Advocacy, Representation, and Hope Via AbbVie's Clearly Me Campaign

More Clinicians are Needed in the Fight Against Skin Cancer

Andrew Baker, MBA, MPAS, PA-C, discusses his role in skin cancer detection and advice for PAs interested in skin surgeries and Mohs closures.

Dose Escalation of Biologic PsO Treatment in Japan

A study out of Japan found some biologics used to treat psoriasis may require higher dose escalation than others.

My Patient Claims He Has a Property Right Forcing Me to Treat Him. What Does That Mean?

This month's Legal Eagle column examines if patients have a legal property right to health care, given public funding of medical education.

IL-17 Pathway Linked to HIF-1-alpha Activation in Psoriasis

Researchers from NYU Langone recently published a study clarifying the role of HIF-1-alpha in inflammation and psoriasis, which has been unclear until now.

VYN201 for Vitiligo: Promising Data Showcases Potential of BET Inhibition

VYNE Therapeutics' Iain Stuart, PhD, spoke with Dermatology Times to discuss recent phase 1 and pre-clinical data for VYN201 for vitiligo.

Mohs Surgical Training Around the World: Need for Standardized Database

While MMS is recognized as the gold standard for skin cancer treatment, numerous challenges still hinder widespread adoption and practice.

FDA Updates PDUFA Date of Subcutaneous Nivolumab

The new action date is December 29, 2024.

Acne-Specific Quality of Life Questionnaire Developed

A new acne-specific HRQoL questionnaire developed in Europe could help to create more comprehensive, individualized treatment plans.

Adding Oral Tranexamic Acid to Traditional Therapies Led to Rapid Improvements in Papulopustular Rosacea

Scores for erythema, dryness, quality of life, and aesthetic improvement were all markedly improved in patients using tranexamic acid versus traditional therapy alone.

Results of Phase 3 BE HEARD Trials of Bimekizumab for HS Published in The Lancet

The Lancet data is the primary publication of bimekizumab results from BE HEARD I and BE HEARD II.

Previewing the 2024 New Wave Dermatology Conference

Tiffani Botts Massey, PA-C, Florida Society of Dermatology PAs President Elect, and Heather Gates, PA-C, the organization's current president, preview the upcoming conference.

Inpatient Dermatology Services, Encounters, and Physicians Experiencing Declines Across the US

Regional disparities were highlighted in a study of inpatient dermatology encounters, locations, and providers from 2013 to 2019.

HRQoL of Patients with Alopecia Areata in Australia

The largest patient study across the continent found a direct link between the extent of hair loss and the negative impact on quality of life.

QUIZ RECAP: Dermoscopy and Melanoma Detection

Earlier this week, we shared our third Skin Cancer Awareness Month quiz. Review the answers and your responses below.

Rehmannia Glutinosa Leaf Extract Led to a Decrease in Acne Severity and Improved Skin Hydration, Quality of Life

Supplementation with RGLE led to clinically significant improvements in patients with acne vulgaris, according to a study.

Pharmacists May Require Additional Training on Corticophobia in Atopic Dermatitis

Misinformation regarding the use of corticosteroids remains persistent and may have implications on patient care.

Dermatology News Affecting Military Service Members

ICYMI: 5 news headlines that impact the treatment of scars, wounds, melanoma, and other skin conditions impacting veterans and active military personnel.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.